Codexis Logo - September 2023.png
Codexis Announces New Employment Inducement Grants
September 06, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as...
Codexis Logo - September 2023.png
Codexis to Participate in Upcoming Healthcare Conferences
September 03, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming investor...
Codexis Logo - September 2023.png
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
August 20, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a presentation and panel...
Codexis Logo - September 2023.png
Codexis Announces New Employment Inducement Grants
August 16, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as...
Codexis Logo - September 2023.png
Codexis Publishes FY2023 Sustainability Disclosures
August 15, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the publication of its inaugural sustainability...
Codexis Logo - September 2023.png
Codexis Reports Second Quarter 2024 Financial Results
August 08, 2024 16:05 ET | Codexis, Inc.
Company Reiterates Full-year Financial Guidance; On Track to Achieve Product Revenue Growth of at Least 10% vs. FY2023 Excluding Enzyme Sales Related to PAXLOVID™ Anticipate Entering First Technical...
Codexis Logo - September 2023.png
Codexis to Report Second Quarter 2024 Financial Results on August 8
July 18, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the second...
Codexis Logo - September 2023.png
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
July 01, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an asset purchase agreement with...
Codexis Logo - September 2023.png
Codexis to Participate in Jefferies Global Healthcare Conference
May 22, 2024 16:25 ET | Codexis, Inc.
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare...
Codexis Logo - September 2023.png
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
May 20, 2024 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a panel discussion titled,...